AU2420997A - Oligopeptides for drug delivery - Google Patents

Oligopeptides for drug delivery

Info

Publication number
AU2420997A
AU2420997A AU24209/97A AU2420997A AU2420997A AU 2420997 A AU2420997 A AU 2420997A AU 24209/97 A AU24209/97 A AU 24209/97A AU 2420997 A AU2420997 A AU 2420997A AU 2420997 A AU2420997 A AU 2420997A
Authority
AU
Australia
Prior art keywords
oligopeptides
drug delivery
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24209/97A
Inventor
Sam J Milstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emisphere Technologies Inc
Original Assignee
Emisphere Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Technologies Inc filed Critical Emisphere Technologies Inc
Publication of AU2420997A publication Critical patent/AU2420997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU24209/97A 1996-02-29 1997-02-28 Oligopeptides for drug delivery Abandoned AU2420997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1257396P 1996-02-29 1996-02-29
US60012573 1996-02-29
PCT/US1997/004051 WO1997031938A1 (en) 1996-02-29 1997-02-28 Oligopeptides for drug delivery

Publications (1)

Publication Number Publication Date
AU2420997A true AU2420997A (en) 1997-09-16

Family

ID=21755607

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24209/97A Abandoned AU2420997A (en) 1996-02-29 1997-02-28 Oligopeptides for drug delivery

Country Status (4)

Country Link
EP (1) EP0883629A1 (en)
AU (1) AU2420997A (en)
CA (1) CA2247048A1 (en)
WO (1) WO1997031938A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773647A (en) * 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
MXPA06013384A (en) 2004-05-19 2007-03-01 Emisphere Tech Inc Topical cromolyn formulations.
CN1968699B (en) 2004-05-19 2010-12-15 爱密斯菲尔科技公司 Acyclovir formulations
ES2535311T3 (en) 2004-12-29 2015-05-08 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
EP2040718B1 (en) 2006-06-28 2017-12-27 Emisphere Technologies, Inc. Gallium nitrate formulations
EP2461803B1 (en) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06107682A (en) * 1992-09-30 1994-04-19 Suntory Ltd Baccharin-like mollusk neuropeptide

Also Published As

Publication number Publication date
WO1997031938A1 (en) 1997-09-04
CA2247048A1 (en) 1997-09-04
EP0883629A1 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
AU6075198A (en) Drug delivery system for two or more active substances
AU6876498A (en) Intravesical drug delivery system
AU6140598A (en) Multipathway electronically-controlled drug delivery system
AU6956398A (en) Implant delivery system
AU7493398A (en) Pulsatile drug delivery system
AU2172997A (en) Materials delivery device
AU1713799A (en) Product delivery device
AU3204995A (en) Closed drug delivery system
AU7077098A (en) Transdermal delivery system
AU5266698A (en) Directional drug delivery stent
AU4282197A (en) Delivery device
AU2816297A (en) Recipient-dosage delivery system
AU5387898A (en) Pharmaceutical agents
AU4468197A (en) Hyaluronic drug delivery system
AU7706098A (en) Antigen delivery system
AU7711098A (en) Drug delivery system
AU8374498A (en) Combination counter-ejector shingle-output delivery system
AU7201998A (en) Drug delivery system
AU3837999A (en) Drug delivery device
AU2420997A (en) Oligopeptides for drug delivery
EP1021137A4 (en) Drug delivery system
AU5154498A (en) Peptides for gene delivery
AU3481497A (en) Chitosan drug delivery system
AU9587198A (en) Immediate release drug delivery forms
AU1671997A (en) Drug delivery system using galactoxyloglucan